We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Mining and analysis of security alert signals of valbenazine based on the Food and Drug Administration Adverse Event Reporting System database.
- Authors
Wang, Qi; Qu, Kankan; Du, Zhiqiang; Shen, Yuan; Jiang, Ying; Zhu, Haohao
- Abstract
Background: Valbenazine is used for tardive movement disorders in adults. Current studies on its safety are mostly from clinical trials and small case reports, limiting information on rare adverse reactions. This study investigated valbenazine-related adverse event (AE) risk signals using the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database. Methods: Valbenazine AEs data were collected from the FAERS database from 2017 Q2 to 2023 Q1, employing methods like reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian confidence propagation neural network, and empirical Bayesian geometric mean. Results: After data cleaning and drug screening, there were 20,837 AEs primarily suspecting valbenazine, involving 26 system organ classes and 125 AEs related to valbenazine at the preferred terms level. AEs related to valbenazine were mainly concentrated in nervous system disorders, general disorders and administration site conditions, and psychiatric disorders. Eye disorders and gastrointestinal disorders are new AEs not labeled in the valbenazine instructions. In addition, some new potential AE signals were found, such as Tardive dyskinesia and eyelid function disorder. Conclusion: The common AEs of valbenazine in the real world are consistent with the instructions, but there are some newly discovered suspicious AEs.
- Subjects
UNITED States. Food &; Drug Administration; DRUG side effects; DATABASES; TARDIVE dyskinesia; DATA scrubbing; NERVOUS system
- Publication
Journal of Psychopharmacology, 2024, Vol 38, Issue 6, p562
- ISSN
0269-8811
- Publication type
Article
- DOI
10.1177/02698811241248391